VXRT
Vaxart Inc
0.449$
-1.1%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 88.7% | 89.2% | 99.6% | 99.5% | 41.6% | 47.5% | 84.2% | 76.5% | 64.6% | 49.6% | 41.0% | 73.2% | |
| 71.7% | 56.3% | 68.4% | 44.1% | 32.5% | 36.5% | 83.1% | 65.0% | 28.6% | 37.8% | 15.2% | 28.9% | |
| 71.7% | 72.5% | 94.9% | 96.3% | 32.5% | 36.5% | 83.1% | 75.3% | 60.9% | 43.2% | 31.1% | 34.3% | |
| 16.4% | 15.9% | 1.0% | 1.5% | 5.1% | 9.8% | 0.2% | 0.0% | 0.0% | 3.3% | 7.2% | 27.6% | |
| 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | 0.1% | 0.0% | 1.3% | 0.0% | – | – | |
| 0.2% | 0.4% | 0.3% | 1.8% | 3.0% | 0.6% | 1.0% | 3.0% | 10.1% | – | – | – | |
| 0.0% | 0.0% | 0.0% | – | – | – | 0.0% | 2.0% | 2.9% | 4.9% | 2.7% | 2.4% | |
| 0.0% | 0.1% | 0.1% | 0.1% | 55.1% | 46.2% | 10.1% | 4.8% | 3.3% | 4.7% | 2.1% | 1.5% | |
| 23.8% | 12.5% | 36.5% | 53.4% | 68.1% | 65.0% | 19.1% | 15.2% | 28.1% | 37.1% | 64.6% | 52.8% | |
| 23.6% | 11.3% | 12.7% | 14.7% | 21.2% | 24.8% | 7.7% | 4.9% | 11.6% | 14.9% | 54.6% | 46.6% | |
| 0.2% | 0.3% | 0.6% | 0.5% | 4.7% | 2.3% | 3.2% | 0.8% | 1.5% | 7.1% | 4.3% | 1.6% | |
| 2.5% | 2.4% | 5.4% | 3.5% | 2.7% | 2.3% | 1.4% | 1.8% | 3.6% | 1.7% | 4.2% | 11.6% | |
| 0.0% | 0.4% | 0.1% | 96.6% | 5.5% | – | – | – | – | – | – | – | |
| 76.2% | 87.5% | 63.5% | 46.6% | 31.9% | 35.0% | 80.9% | 84.8% | 71.9% | 62.9% | 35.4% | 47.2% | |
| -78.8% | -137.2% | -184.7% | -408.5% | -278.2% | -315.0% | -97.6% | -99.2% | -212.6% | -446.0% | -286.4% | -247.3% | |
| 25.0% | 40.5% | 48.3% | 8.8% | 179.3% | 582.5% | 319.3% | 220.3% | 316.7% | 530.6% | 292.8% | 123.8% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.